Abiopharma

News list

Chapman Steven Leonard 🟡 adjusted position in 0 shares of Natera, Inc. (NTRA) at $204.13 ($1.1M) Transaction Date: Mar 09, 2026 | Filing ID: 000008

Full text

News bot March 12, 2026, 1:35 a.m.
🔍 Chapman Steven Leonard (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 5,623
- Total shares sold: 5,623
Detailed Transactions and Holdings:
- Acquired 5,623 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 162,230.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Sold 5,623 shares of Common Stock at $204.1327 per share (Direct)
  Date: 2026-03-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 156,607.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs were fully-vested at the time of issuance.
- F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- F3: The sale of shares was partially effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 9, 2026.